On the stock market since 2020, it operates in the world of health and science. It has 339 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 19% a year over the last 4 years. Red columns mark years that ended in a loss.
If every debt were paid off today, $92.6M would still be left in the vault — a solid cushion for hard times.
angles, checked one by one.
The 4 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
R&D Investment: Spending on future research is low.
An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Over the last 3 years, sales grew about 24% a year on average.
There is $92.6M in the vault; even if every debt were paid off, $92.6M would remain.
The stock sits at $0.0002. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
The company’s market value is 112 times its annual profit. Even a small disappointment could hit the price hard.
On our five-subject report card, TALKW sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: TALKW is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.